Imperial Capital’s Michael Derchin and Adam Hackel contend that American Airlines’ (AAL) “strong management skills [will] be tested once again.” They explain why:
American Airlines
We are initiating coverage ofAmerican Airlines shares with an In-Line rating and a one-year price target of $40, about 9% above the recent share price. One of the most under-appreciated management achievements in recent years, in our view, was AAL’s ability to report record net profit and pretax margins while flawlessly executing the Herculean integration of AMR and US Airways. Added to the challenges were two major headwinds: 1) the disintegration of its most profitable geographic region, Latin America, as Venezuela and Brazil economies imploded, and 2) the sunset of the Wright Amendment, which unleashed the low fares of Southwest Airlines (LUV), which in turn undermined the profitability of AAL’s very profitable Dallas/Fort Worth hub.
stock market best investments: Cerner Corporation(CERN)
Advisors’ Opinion:
- [By Ben Levisohn]
Cerner (CERN) soared to the top of the S&P 500 today after thehealth care information technology company reported better-than-expected earnings and revenue.
Getty Images
Cernergained 7.8% to $64.75 at 5:03 p.m. today, while the S&P 500 declined 0.2% to 2,384.20.
Canaccord Genuity’s Richard Close and Brian Hoffman contend Cerner may be “rediscovered its mojo.” They explain:
We reiterate our BUY rating and raise our PT to $66 (was $59) as the company finally
appears to have provided quarterly and annual targets that it can meet. Possibly more important, analyst expectations sit near the mid-point of guidance, portending upside potential. The outlook appears solid as the company (1) rebuilds a track record of delivering on expectations, (2) reaffirmed confidence in 2017 bookings growth, and (3) has a strengthened pipeline for ITWorks and revenue cycle. CERN may have rediscovered its mojo.
Cerner’s market capitalization rose to $21.4 billion today from $19.8 billion yesterday.
- [By Ben Levisohn]
Cerner (CERN) tumbled to the bottom of the S&P 500 today after meetings earnings forecasts but offering below-consensus guidance.
Agence France-Presse/Getty Images
Cerner dropped 4.4% to $51.50 today, while the S&P 500 rose 0.4% to 2,316.10.
SunTrust Robinson Humphrey’s Sandy Draper and team contend that “most of the bad news is already priced in.” They explain:
Although we expect this news to weigh on the stock…we think the market has remained cautious on CERN shares heading into the 4Q16 print given the uneven execution throughout 2016 and the post-election regulatory uncertainty that has broadly weighed on the HCIT space as a whole. We observe that CERN shares closed about 3% below the level they traded at this time last year, while the S&P was up over 21% in that time. The muted 12-month performance in the stock suggests the market rightly anticipated unattractive year-end results and 2017 guidance, which suggests to us that downside to CERN shares should be limited.
Cerner’s market capitalization fell to $17.5 billion today from $18.3 billion yesterday.
Barron’s Vito Racanelli recommended shares of Cerner on March 16, 2016, when the stock traded at $51.46.
stock market best investments: Swift Transportation Company(SWFT)
Advisors’ Opinion:
- [By Craig Jones]
On CNBC's Fast Money Halftime Report, Jon Najarian said he noticed unusually high volume in the April 23 calls in Swift Transportation Co (NYSE: SWFT) on Wednesday. Traders bought around 3,500 contracts in the first half of the trading session and they $1 paid for them. The trade breaks even at $24 or 8.45 percent above the current market price. Jon Najarian followed the trade and he is planning to hold the position for two weeks.
- [By Teresa Rivas]
Swift Transportation (SWFT) is up 18.2% on news that it will merge with Knight Transportation (KNX), up 11%.
Endo International(ENDP) is up 4.3% after preannouncing first-quarter earnings in line with analysts’ estimates.
Tesla (TSLA) is up 1.9% after Piper Jaffray upgraded the stock to Buy from Neutral.
J.M. Smucker (SJM) is down 1.1% after Morgan Stanley cut it to Underweight from Equal Weight.
Hilton Worldwide(HLT) is up 1.9% after Goldman Sachs upgraded it to Conviction Buy from Buy.
Ulta Beauty(ULTA) is up 0.7% after Loop Capital upgraded it to Buy from Hold.
Canada Goose (GOOS) is up 1.5% after a number of firms, including Goldman Sachs, Barclays, BMO Capital Markets, and Canaccord initiated coverage of the stock with a Buy rating, although it also got a few Hold ratings. as well.
- [By Rich Smith]
Knight Transportation (NYSE:KNX) is merging with Swift Transportation (NYSE:SWFT) to build a $5 billion trucking behemoth — and Wall Street thinks that’s a good thing.
stock market best investments: Francesca's Holdings Corporation(FRAN)
Advisors’ Opinion:
- [By Ben Levisohn]
Francesca’s Holdings (FRAN) has jumped 5.4% to $11.00 after beating earnings forecasts.
Restoration Hardware (RH) has tumbled 20% to $28.92 after slashing its full-year guidance. Restoration Hardware was also cut to Market Perform from Outperform at Telsey Advisory Group.
- [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.
stock market best investments: Celgene Corporation(CELG)
Advisors’ Opinion:
- [By JACK HOUGH]
Celgene’s main risk is a little like AMC’s zombies. It will generate more than 60% of its revenue this year from a single medicine called Revlimid, used primarily to treat a type of cancer called multiple myeloma. But Revlimid is gaining regulatory approval for an expanding number of uses. It has plenty of growth potential overseas, and shows promise in combination therapies. And it has more than a decade of remaining patent protection. Analysts predict double-digit yearly revenue growth for Revlimid through the end of the decade.
By then, Celgene is expected to have four drugs with yearly sales in the billions of dollars, versus just Revlimid today. And a robust pipeline of medicines in development provides ample opportunity for new successes. Management has set a goal of $21 billion in yearly revenue by 2020, up from a projected $9.2 billion this year. If it’s successful, two things are likely to happen. First, Revlimid’s contribution is likely to drop below half of revenue by then. Second, earnings per share could more than double, as Celgene’s growing size offers better leverage on its research and marketing expenses. Shares sell for 22 times this year’s earnings consensus—inexpensive considering the growth outlook.
- [By Todd Campbell]
Keeping tabs on what iconic billionaire investors George Soros, Warren Buffett, and Carl Icahn are doing with their money can help you find new money-making ideas. What have Soros, Buffett, and Icahn been buying lately? According to reports,Celgene Corp (NASDAQ:CELG), Apple Inc. (NASDAQ:AAPL), and Bristol-Myers Squibb (NYSE:BMY)are among the stocks they’ve recently been adding to their portfolios. Since these companies have catalysts that could send shares higher, it might be time to buy them in your portfolio, too.
- [By Todd Shriber, ETF Professor]
Several big-name biotech companies step into the earnings confessional starting in the middle of the week, with Amgen, Inc. (NASDAQ: AMGN), Anthem Inc (NYSE: ANTM), and Celgene Corporation (NASDAQ: CELG) among the companies in play. That could bring opportunity with the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) and the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD).
- [By Lisa Levin]
In trading on Thursday, healthcare shares fell 0.79 percent. Meanwhile, top losers in the sector included Celgene Corporation (NASDAQ: CELG), down 18 percent, and Anika Therapeutics Inc (NASDAQ: ANIK) down 11 percent.
stock market best investments: TransEnterix, Inc.(TRXC)
Advisors’ Opinion:
- [By Lee Jackson]
Ahuge 10% owner of TransEnterix Inc. (NYSE: TRXC) camein and bought more shares last week. SOFAR SpA added3,722,685 more shares of the medical device companys stock at a reported $1.40 apiece. The total for the trade was posted at $5,226,650.
- [By Lisa Levin]
Transenterix Inc (NASDAQ: TRXC) was down, falling around 38 percent to $0.681. TransEnterix reported the pricing of $24.9 million public offering of common stock and warrant.
- [By Jim Robertson]
On Friday, four out of ten of the worst performing small cap stocks had double digit losses due to announcing public stock offerings:
Medical device stock Transenterix Inc (NYSEMKT: TRXC) sank 40.37% after announcing a $24.9 million offeringand the pricing of its public offering of units, each consisting of one share of the Companys common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to purchase 0.75 shares of common stock at a price of $1.00 per unit:
